The global non-opioid pain treatment market is expected to increase by USD 31 十亿, 以复合年增长率 (复合年增长率) 的 16.1% 从 2022 到 2028, according to the latest edition of the Global Non-opioid Pain Treatment Market Report.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global non-opioid pain treatment market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the non-opioid pain treatment industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, 应用, 和地区. The global market for non-opioid pain treatment can be segmented by product: botulinum toxin, capsaicin, medical cannabis, menthol, omega 3 fatty acids. The medical cannabis segment held the largest share of the global non-opioid pain treatment market in 2021 预计在预测期内将持有其份额. Non-opioid pain treatment market is further segmented by application: cancer pain, musculoskeletal pain, neuropathic pain, 其他的. 全球范围, the musculoskeletal pain segment made up the largest share of the non-opioid pain treatment market. 根据地区, the non-opioid pain treatment market is segmented into: 亚太地区, 欧洲, 北美, 世界其他地区 (排). North America was the largest contributor to the global non-opioid pain treatment market in 2021.

副产品:
– botulinum toxin
– capsaicin
– medical cannabis
– menthol
– omega 3 fatty acids

按申请:
– cancer pain
– musculoskeletal pain
– neuropathic pain
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The cancer pain market is further segmented into brain, 胸部, colorectal, leukemia/lymphoma, melanoma, prostate, 其他的. 在 2021, the breast segment made up the largest share of revenue generated by the non-opioid pain treatment market. 此外, the neuropathic pain market has been categorized into diabetes, epilepsy, 偏头痛, multiple sclerosis, 其他的. 在这些当中, the diabetes segment was accounted for the highest revenue generator in 2021. The musculoskeletal pain market is further divided into arthritis, fibromyalgia, 其他的. The arthritis segment captured the largest share of the market in 2021 预计在预测期内将保持其主导地位.

The report also provides a detailed analysis of several leading non-opioid pain treatment market vendors that include Allergan plc (艾伯维公司), Aurora Cannabis Inc., Bedrocan Cannabis Corp., Canopy Growth Corporation, Cara Therapeutics, 公司, Centrexion Therapeutics Corporation, Cronos Group Inc., GW Pharmaceuticals plc, Medical Marijuana, 公司, Tilray Brands, 公司. (Aphria Inc.), 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global non-opioid pain treatment market.
– To classify and forecast the global non-opioid pain treatment market based on product, 应用, 地区.
– To identify drivers and challenges for the global non-opioid pain treatment market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global non-opioid pain treatment market.
– To identify and analyze the profile of leading players operating in the global non-opioid pain treatment market.

为什么选择这份报告
– Gain a reliable outlook of the global non-opioid pain treatment market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.